Novo Nordisk CEO touts new drugs as investors remain wary
WSJ reports Novo Nordisk CEO Mike Doustdar said the company will launch several new blockbusters over the next few years, but investors are not yet convinced growth path is imminent.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.